Nadeem Riaz

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Supplementary Figures from Genomic Enrichment and Functional Impact of <i>TP53</i> and <i>CYLD</i> Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer

  2026-06-19

• Data from Genomic Enrichment and Functional Impact of <i>TP53</i> and <i>CYLD</i> Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer

  2026-06-19

• Supplementary Tables from Genomic Enrichment and Functional Impact of <i>TP53</i> and <i>CYLD</i> Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer

  2026-06-19

• PSG copy number amplification and association with poor survival in early-stage female lung adenocarcinoma patients.

  Journal of Clinical Oncology · 2026-05-28

• Pilot study of HB-200 in patients with HPV16+ head and neck squamous cell carcinoma and detectable TTMV-HPVDNA after definitive therapy.

  Journal of Clinical Oncology · 2026-05-28

• Long-term outcomes of ¹⁸ F-fluoromisonidazole positron emission tomography (FMISO PET)–guided major radiation dose de-escalation in HPV-associated oropharyngeal cancer: The 30 ROC approach.

  Journal of Clinical Oncology · 2026-05-27

• Induction chemotherapy response–guided selection for hypoxia-directed major radiation de-escalation in T3–T4 HPV-positive oropharyngeal cancer.

  Journal of Clinical Oncology · 2026-05-27

• Nonoperative management of locally advanced resectable cutaneous squamous cell cancer of the head and neck with PD-1 blockade.

  Journal of Clinical Oncology · 2026-05-27

• Genomically personalized radiation dose de-escalation: A phase II basket radiation study in patients with pathogenic mutations in <i>ATM</i> .

  Journal of Clinical Oncology · 2026-05-27

• Proton versus photon therapy for oropharyngeal cancer

  The Lancet · 2026-05-01

• Staging of non-metastatic nasopharyngeal carcinoma with PET/CT

  European Radiology · 2026-04-20

• Abstract 1024: CIN signatures as biomarkers of drug sensitivity: Real-world evidence from DNA targeted sequencing data

  Cancer Research · 2026-04-03

• Abstract 96: Real time multimodal ctDNA and imaging assessment enables adaptive treatment in HPV related oropharyngeal cancer.

  Cancer Research · 2026-04-03

• Abstract 2615: Diffusion kurtosis imaging to predict tumor hypoxia and recurrence in HPV-associated oropharyngeal cancer.

  Cancer Research · 2026-04-03

• Abstract 7291: Hypoxia selects for early PI3K pathway alterations and drives clonal complexity in HPV-positive oropharyngeal cancer

  Cancer Research · 2026-04-03

• Abstract 5254: Copy number amplification of PSG is associated with poor survival in female lung adenocarcinoma patients

  Cancer Research · 2026-04-03

• Dosimetric Results for Organs at Risk From Radiation Therapy Dose De-Escalation to the Subclinical Region in Human Papillomavirus–Associated Oropharyngeal Cancer: A Propensity Score–Matched Analysis

  International Journal of Radiation Oncology*Biology*Physics · 2026-04-01

• Expanding the Histologic Spectrum of Human Papillomavirus (HPV)-Associated Oropharyngeal Carcinoma: A Retrospective Study of 379 Cases Focusing on Classification, Histologic Features, and their Prognostic Significance

  Head and Neck Pathology · 2026-03-26 · 1 citations

• POLAR Trial | WES | cfDNA | mIF Correlative raw data and R script

  Figshare · 2026-03-26

• POLAR Trial | WES | cfDNA | mIF Correlative raw data and R script

  Figshare · 2026-03-26